Stem Point Capital LP Insmed Inc Transaction History

Stem Point Capital LP

  • $334 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$22.0 - $69.71 $4.08 Million - $12.9 Million
-185,468 Reduced 68.07%
86,980 $5.83 Billion
Q1 2024

May 13, 2024
BUY
$25.72 - $29.94 $2.54 Million - $2.96 Million
98,869 Added 56.96%
272,448 $7.39 Billion
Q4 2023

Feb 12, 2024
BUY
$23.42 - $31.74 $4.07 Million - $5.51 Million
173,579 New
173,579 $5.38 Billion

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email